|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI
|
|
2
|
Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB and Chang GJ: Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 150:17–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, Cao Y, Bray F and Jemal A: Colorectal cancer incidence trends in younger versus older adults: An analysis of population-based cancer registry data. Lancet Oncol. 26:51–63. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kantarjian H, Pui CH and Jabbour E: Acute lymphocytic leukaemia. Lancet. 406:950–962. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ni H, Shi Y, Wang M and Ji C: Analysis of global, regional, and national burden and attributable risk factors of acute lymphoblastic leukemia and acute myeloid leukemia from 1990 to 2021. PLoS One. 20:e03304792025. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nuha N, Higgins SP, Czekay RP, Higgins CE, Guo L, Lee H and Higgins PJ: SERPINE1 drives molecular synergies in colorectal cancer. Am J Physiol Cell Physiol. 330:C9–C25. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Basheer MI, Rana IA, Sheikh UN, Yusuf MA, Sindhu II and Loya A: Presentation of acute lymphoblastic lymphoma and colorectal carcinoma in the context of constitutional mismatch repair deficiency syndrome: A case report with literature review. J Cancer Allied Spec. 8:e4432022.PubMed/NCBI
|
|
8
|
Bloomfield CD, Lindquist LL, Arthur D, McKenna RW, LeBien TW, Nesbit ME and Peterson BA: Chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res. 41((11 Pt 2)): 4838–4843. 1981.PubMed/NCBI
|
|
9
|
Garcia C, Miller-Awe MD and Witkowski MT: Concepts in B cell acute lymphoblastic leukemia pathogenesis. J Leukoc Biol. 116:18–32. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pui CH, Carroll WL, Meshinchi S and Arceci RJ: Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol. 29:551–565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
National Comprehensive Cancer Network, . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Acute Lymphoblastic Leukemia. Version 2.2025. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1410January 25–2026
|
|
12
|
Wang Y: Interpretation of Chinese guideline for diagnosis and treatment of adult acute lymphoblastic leukemia (2024). J Clin Hematol (China). 37:453–456. 2024.(In Chinese).
|
|
13
|
Paolino J, Tsai HK, Harris MH and Pikman Y: IKZF1 alterations and therapeutic targeting in B-cell acute lymphoblastic leukemia. Biomedicines. 12:892024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang BQ, Cai ZH, Lin DN, Wang ZX, Liang XJ, Fan ZP, Huang F, Liu QF and Zhou HS: Prognostic significance of IKZF1 gene deletions in patients with B-cell acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi. 43:235–240. 2022.(In Chinese). PubMed/NCBI
|
|
15
|
Deng SY, Ou JW, Huang ZC, Chen JJ, Cai ZH, Liu QF and Zhou HS: The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi. 45:257–263. 2024.(In Chinese). PubMed/NCBI
|
|
16
|
Ou JW, Deng SY, Li J, Huang ZC, Cai ZH, Lin JP, Chen YF and Zhou HS: Synergistic effect of chidamide and venetoclax in IKZF1 deletion acute B lymphoblastic leukemia cells and its mechanism. Abstract P380. Eur Hematol Assoc Annu Congr. June 13-16–2024.Madrid, Spain.
|
|
17
|
Zhao L, Sun L, Kong D, Cao R, Guo Z, Guo D, Li Q, Hao J, Li Y and Emails L: Chidamide and venetoclax synergistically regulate the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL. Ann Hematol. 104:489–501. 2025.PubMed/NCBI
|
|
18
|
Hanbali A, Kotb A and Saleh M: B-Cell lymphoma 2 inhibition in acute lymphoblastic leukemia: Mechanisms, resistance, and emerging combinations with venetoclax. J Hematol. 14:193–201. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jen EY, Xu Q, Schetter A, Przepiorka D, Shen YL, Roscoe D, Sridhara R, Deisseroth A, Philip R, Farrell AT and Pazdur R: FDA approval: Blinatumomab for patients with b-cell precursor acute lymphoblastic leukemia in morphologic remission with minimal residual disease. Clin Cancer Res. 25:473–477. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bassan R, Chiaretti S, Della Starza I, Santoro A, Spinelli O, Tosi M, Elia L, Cardinali D, De Propris MS, Piccini M, et al: Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: The GIMEMA LAL2317 phase 2 study. Blood. 145:2447–2459. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu J, Zhou H, Zhou X, Yang Y, Tong L, Miao M, Yang X and Chen S: Reduced-dose chemotherapy followed by blinatumomab in induction therapy for newly diagnosed B-cell acute lymphoblastic leukemia. Cancer Med. 13:e70622024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chinese Society of Clinical Oncology, . Guidelines of Chinese Society of Clinical Oncology (CSCO) Hematological Malignancies. People's Medical Publishing House; Beijing, China: 2025, (In Chinese).
|
|
23
|
Bhattacharjee S, Ghosh S and Bhattacharyya M: Bleeding per rectum during induction chemotherapy: Looking beyond the leukaemia-2 case reports and review of literature. Indian J Cancer. 59:560–564. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang H, Chuang WY, Shih LY and Tang TC: Collision in the colon: concurrent adenocarcinoma and diffuse large B-cell lymphoma in the same tumour. Acta Clin Belg. 66:302–304. 2011.PubMed/NCBI
|
|
25
|
Tian S, Wu F, Yang F, Min G and Chen H: Laparoscopic surgery for synchronous double colorectal cancer with obstruction, plus small B cell lymphoma: A case report. J Surg Case Rep. 2025:rjae8302025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujita H, Morohashi H, Sakamoto Y, Miura T, Sato K, Mitsuhashi Y, Umemura K, Ogasawara H, Hara Y, Kanda T, et al: A case of descending colon and rectal cancer with acute myeloid leukemia performed robot-assisted hartmann's procedure. Gan To Kagaku Ryoho. 48:599–601. 2021.(In Japanese). PubMed/NCBI
|
|
27
|
Prabakaran S, Senthilnathan SV, Venkatadesikalu M, Prasad N and Sridharan S: Adenocarcinoma of the colon as a second malignancy in a child. Pediatr Surg Int. 17:475–477. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagata K, Fushimi K, Sugiura K, Miyake S, Maruyama H, Murohashi I and Murakami N: A case of successful surgical treatment of rectal cancer complicated by acute myelomonocytic leukemia. Gan No Rinsho. 33:1945–1949. 1987.(In Japanese). PubMed/NCBI
|
|
29
|
Yashige H and Fujii H: Ph1 positive acute lymphoblastic leukemia with DIC after operation of colon and lung cancer. Rinsho Ketsueki. 30:1074–1078. 1989.(In Japanese). PubMed/NCBI
|
|
30
|
Alkhayyat S: Rectal cancer complicated by acute promyelocytic leukemia. Cureus. 12:e111182020.PubMed/NCBI
|
|
31
|
Zarrabi MH and Rosner F: Acute myeloblastic leukemia following treatment for non-hematopoietic cancers: Report of 19 cases and review of the literature. Am J Hematol. 7:357–367. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Abbaoui S, Zaari N, Ammor A and Benhaddou H: Adenocarcinoma of the colon in children with LAL: A case report. Int J Surg Case Rep. 121:1099952024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu B, Liu M, Mu T, Li W, Ren J, Li X, Liang Y, Yang Z, Niu Y, Chen S and Lin J: Quadruple primary tumors in a lynch syndrome patient surviving more than 26 years with genetic analysis: A case report and literature review. Front Oncol. 14:13821542024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tailor IK, Cook J, Reilly JT, Dalley CD, Ezaydi Y, Kelsey PJ and Snowden JA: Acute myeloid leukaemia associated with Muir-Torre variant of hereditary non-polyposis colon cancer (HNPCC): Implications for inherited and acquired mutations in DNA mismatch repair genes. Br J Haematol. 156:289–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lung Cancer Medical Education Committee of the Chinese Medical Education Association; Lung Cancer Alliance of Chinese Thoracic Surgery; Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association; Tumor Ablation Expert Committee of the Chinese Society of Clinical Oncology; Tumor Ablation Expert Group of the Chinese College of Interventionalists, . Chinese expert consensus: multidisciplinary diagnosis and treatment of multiple ground-glass nodule like lung cancer (2024 edition). Zhonghua Nei Ke Za Zhi. 63:153–169. 2024.(In Chinese). PubMed/NCBI
|
|
36
|
Garutti M, Foffano L, Mazzeo R, Michelotti A, Da Ros L, Viel A, Miolo G, Zambelli A and Puglisi F: Hereditary cancer syndromes: A comprehensive review with a visual tool. Genes (Basel). 14:10252023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma H, Brosens LAA, Offerhaus GJA, Giardiello FM, de Leng WWJ and Montgomery EA: Pathology and genetics of hereditary colorectal cancer. Pathology. 50:49–59. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pedroni M, de Leon MP, Bonetti LR, Rossi G, Viel A, Urso EDL and Roncucci L: Biallelic PMS2 mutations in a family with uncommon clinical and molecular features. Genes (Basel). 13:19532022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chinese Society of Clinical Oncology, . Guideline of Chinese Society of Clinical Oncology (CSCO) Colorectal Cancer. People's Medical Publishing House; Beijing, China: 2025
|
|
40
|
Baden D, Wolgast N, Altrock PM, Steinhäuser S, Voran J, Beder T, Hecht M, Baden C, Bastian L, Ronckers C, et al: Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: A nationwide population-based registry analysis. Lancet Reg Health Eur. 59:1015032025. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
National Comprehensive Cancer Network, . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Colon Cancer. Version 5.2025. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1428February 6–2026
|
|
42
|
Argilés G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, Laurent-Puig P, Quirke P, Yoshino T and Taieb J: Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 31:1291–1305. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nors J, Iversen LH, Erichsen R, Gotschalck KA and Andersen CL: Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: A nationwide danish cohort study. JAMA Oncol. 10:54–62. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C, et al: Evidence for cure by adjuvant therapy in colon cancer: Observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 27:872–877. 2009. View Article : Google Scholar : PubMed/NCBI
|
